Nanobiotix is trading 6.78% down at $35.60, with no clear company-specific announcement identified for September 9, 2026.
- Broader risk-off sentiment and geopolitical concerns are weighing on equities, though major-index declines remain relatively modest.
- The decline appears unexplained by a confirmed company catalyst; continued selling pressure warrants monitoring for delayed news.